Skip to main content
. 2020 Oct 24;2020(10):CD013256. doi: 10.1002/14651858.CD013256.pub2

Myrelid 2014.

Study characteristics
Methods Retrospective cohort. Study period not provided
Participants Country: Sweden. CD patients who underwent resection with primary anastomoses and/or stirctureplasties. Patients with stomas were excluded
Interventions 1. Preoperative infliximab (n= 111) within 2 months of surgery
2. No preoperative infliximab (n= 187)
Outcomes Infectious complications within 30 days of surgery
Notes NOS very high risk of bias overall
Unadjusted ORs for preoperative steroids, immunomodulators and anti‐TNF were o btained from regression analysis.
Risk of bias
Bias Authors' judgement Support for judgement
Representativeness of the exposed cohort Low risk CD patients who underwent resection with primary anastomoses and/or stirctureplasties.
Selection of the non exposed cohort Low risk Both groups obtained from the same hospital database and time period
Ascertainment of exposure Low risk Data obtained from database
Demonstration that outcome of interest was not present at start of study High risk Indication for surgery was abscess/fistula in 61 patients
Comparability of cohorts (Controlled for critical factor/other medications) High risk Univariate analysis
Comparability of cohorts (Controlled for additional factor) High risk Univariate analysis
Assessment of outcome Low risk Data obtained from database
Was follow‐up long enough for outcomes to occur Low risk 30 days
Adequacy of follow up of cohorts Unclear risk No information provided